<?xml version="1.0" encoding="UTF-8"?><Media xmlns:cdr="cips.nci.nih.gov/cdr" BlockedFromVOL="Yes">
 
 <MediaTitle>Childhood Soft Tissue Sarcoma - Risk Stratification and Treatment Assignment</MediaTitle>
 <PhysicalMedia>
  <ImageData>
   <ImageType>chart</ImageType>
   <ImageEncoding>JPEG</ImageEncoding>
   <Color>BW</Color>
   <Labeled>Yes</Labeled>
   <LabelName language="en">Diagnosis of eligible soft tissue sarcoma</LabelName><LabelName language="en">Non-metastatic</LabelName><LabelName language="en">Grossly Resected</LabelName><LabelName language="en">Tumor Grade</LabelName><LabelName language="en">Low</LabelName><LabelName language="en">Microscopic margins</LabelName><LabelName language="en">- or +</LabelName><LabelName language="en">Arm A</LabelName><LabelName language="en">Observation</LabelName><LabelName language="en">High</LabelName><LabelName language="en">Maximal Tumor Diameter</LabelName><LabelName language="en">≤5cm</LabelName><LabelName language="en">Microscopic Margins -</LabelName><LabelName language="en">Microscopic Margins +</LabelName><LabelName language="en">Arm B</LabelName><LabelName language="en">Adjuvant radiotherapy</LabelName><LabelName language="en">&gt;5cm</LabelName><LabelName language="en">Arm C</LabelName><LabelName language="en">Adjuvant chemo + RT</LabelName><LabelName language="en">Unresected (Unresectable or high grade tumor &gt;5cm where delayed resection planned)</LabelName><LabelName language="en">Arm D</LabelName><LabelName language="en">Neoadjuvant chemoradiotherapy</LabelName><LabelName language="en">Metastatic to lymph nodes and/or distant sites</LabelName><LabelName language="en">Tumor Grade</LabelName><LabelName language="en">Low</LabelName><LabelName language="en">All Disease Resected?</LabelName><LabelName language="en">Yes</LabelName><LabelName language="en">Microscopic margins</LabelName><LabelName language="en">- or +</LabelName><LabelName language="en">Arm A</LabelName><LabelName language="en">Observation</LabelName><LabelName language="en">No</LabelName><LabelName language="en">Assess Resection Status of Primary Tumor</LabelName><LabelName language="en">Grossly resected</LabelName><LabelName language="en">Arm C</LabelName><LabelName language="en">Adjuvant chemo + RT</LabelName><LabelName language="en">Unresected</LabelName><LabelName language="en">Arm D</LabelName><LabelName language="en">Neoadjuvant chemoradiotherapy</LabelName><LabelName language="en">High</LabelName><LabelName language="en">Low Risk</LabelName><LabelName language="en">Intermediate Risk</LabelName><LabelName language="en">High Risk</LabelName><ImageDimensions>
    <HeightPixels>1092</HeightPixels>
    <WidthPixels>1413</WidthPixels>
   </ImageDimensions>
  </ImageData>
 </PhysicalMedia>
 <MediaSource>
  <OriginalSource>
   <Creator>Sheri L. Spunt, MD, MBA, Lucile Packard Children’s Hospital at Stanford</Creator>
   <SourcePublication>Spunt SL,  Million L, Anderson JR, et al.: Risk-based treatment for nonrhabdomyosarcoma soft tissue sarcomas (NRSTS) in patients under 30 years of age: Children’s Oncology Group study ARST0332. J Clin Oncol 32 (Suppl 15): A-10008, 2014</SourcePublication><DateCreated>2016-03-30</DateCreated>
   <SourceFilename>Ch STS Spunt Figure 3-29-16.jpg</SourceFilename>
  <Comment audience="Internal" date="2016-03-30" user="kuhlmanna">Image approved by PDQ Pediatric Treatment Editorial Board; permissions received</Comment><Comment audience="Internal" date="2015-11-03" user="kuhlmanna">Permissions needed - needs Board approval; image added as summary placeholder</Comment></OriginalSource>
 </MediaSource>
 <PermissionInformation>
    <PermissionRequested>Yes</PermissionRequested>
    <PermissionRequestDate>2016-03-14</PermissionRequestDate>
    <PermissionResponse>Permission Granted</PermissionResponse>
    <PermissionResponseDate>2016-03-29</PermissionResponseDate>
    
    <PublisherPermissionText>Spunt SL,  Million L, Anderson JR, et al.: Risk-based treatment for nonrhabdomyosarcoma soft tissue sarcomas (NRSTS) in patients under 30 years of age: Children’s Oncology Group study ARST0332. J Clin Oncol 32 (Suppl 15): A-10008, 2014</PublisherPermissionText>
    <ApprovedUse>
     <Summary cdr:ref="CDR0000062934">Childhood Soft Tissue Sarcoma Treatment</Summary>
     
    </ApprovedUse>
    <SpanishTranslationPermissionRequested>No</SpanishTranslationPermissionRequested>
    
    <CitationLink cdr:ref="CDR0000770861">Risk-based treatment for nonrhabdomyosarcoma soft tissue sarcomas (NRSTS) in patients under 30 years of age: Children’s Oncology Group study ARST0332</CitationLink><Comment audience="Internal" date="2016-03-30" user="kuhlmanna">Permissions received; per SQK, image will not be translated into Spanish</Comment></PermissionInformation><MediaContent>
  <Categories>
   <Category>measurement</Category>
  </Categories>
  <Diagnoses>
   <Diagnosis cdr:ref="CDR0000040256">childhood soft tissue sarcoma</Diagnosis>
  </Diagnoses>
  
  <ContentDescriptions>
   <ContentDescription audience="Health_professionals" language="en">Chart showing risk stratification and treatment assignment for the Children's Oncology Group ARST0332 trial.</ContentDescription>
  </ContentDescriptions>
  <Captions>
   <MediaCaption audience="Health_professionals" language="en">Risk stratification and treatment assignment for the Children's Oncology Group ARST0332 trial. Credit: Sheri L. Spunt, MD, MBA</MediaCaption>
  </Captions>
 </MediaContent>
 <ProposedUse>
  <Summary cdr:ref="CDR0000062934">Childhood Soft Tissue Sarcoma Treatment</Summary>
  
 </ProposedUse>
 
<ProcessingStatuses>
       <ProcessingStatus>
        <ProcessingStatusValue>Ready for Publishing</ProcessingStatusValue>
        <ProcessingStatusDate>2016-03-30</ProcessingStatusDate>
        <EnteredBy>kuhlmanna</EnteredBy>
        
       </ProcessingStatus></ProcessingStatuses></Media>
